Literature DB >> 33477301

Respiratory Syncytial Virus G Protein Sequence Variability among Isolates from St. Petersburg, Russia, during the 2013-2014 Epidemic Season.

Vera Krivitskaya1, Kseniya Komissarova1, Maria Pisareva1, Maria Sverlova1, Artem Fadeev1, Ekaterina Petrova1, Veronika Timonina2, Anna Sominina1, Daria Danilenko1.   

Abstract

Human respiratory syncytial virus (RSV) is the most common cause of upper and lower respiratory tract infections in infants and young children. It is actively evolving under environmental and herd immunity influences. This work presents, for the first time, sequence variability analysis of RSV G gene and G protein using St. Petersburg (Russia) isolates. Viruses were isolated in a cell culture from the clinical samples of 61 children hospitalized (January-April 2014) with laboratory-confirmed RSV infection. Real-time RT-PCR data showed that 56 isolates (91.8%) belonged to RSV-A and 5 isolates (8.2%) belonged to RSV-B. The G genes were sequenced for 27 RSV-A isolates and all of them belonged to genotype ON1/GA2. Of these RSV-A, 77.8% belonged to the ON1(1.1) genetic sub-cluster, and 14.8% belonged to the ON1(1.2) sub-cluster. The ON1(1.3) sub-cluster constituted a minor group (3.7%). Many single-amino acid substitutions were identified in the G proteins of St. Petersburg isolates, compared with the Canadian ON1/GA2 reference virus (ON67-1210A). Most of the amino acid replacements were found in immunodominant B- and T-cell antigenic determinants of G protein. These may affect the antigenic characteristics of RSV and influence the host antiviral immune response to currently circulating viruses.

Entities:  

Keywords:  G protein variability; ON1/GA2 genotype; human respiratory syncytial virus; phylogenetic analysis

Year:  2021        PMID: 33477301      PMCID: PMC7830914          DOI: 10.3390/v13010119

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  41 in total

1.  Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection.

Authors:  E E Walsh; C B Hall; M Briselli; M W Brandriss; J J Schlesinger
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

2.  Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes.

Authors:  Gerald E Hancock; Paul W Tebbey; Catherine A Scheuer; Karin S Pryharski; Kristen M Heers; Natisha A LaPierre
Journal:  J Med Virol       Date:  2003-06       Impact factor: 2.327

3.  Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.

Authors:  Matthew B Elliott; Karin S Pryharski; Qingzhong Yu; L A Boutilier; N Campeol; K Melville; Todd S Laughlin; C K Gupta; Robert A Lerch; Valerie B Randolph; Natisha A LaPierre; Kristen M Heers Dack; Gerald E Hancock
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Genetic variability of human respiratory syncytial virus A strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication.

Authors:  Alireza Eshaghi; Venkata R Duvvuri; Rachel Lai; Jeya T Nadarajah; Aimin Li; Samir N Patel; Donald E Low; Jonathan B Gubbay
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

5.  Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

Authors:  T E Sparer; S Matthews; T Hussell; A J Rae; B Garcia-Barreno; J A Melero; P J Openshaw
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

6.  Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins.

Authors:  Sandra Fuentes; Elizabeth M Coyle; Judy Beeler; Hana Golding; Surender Khurana
Journal:  PLoS Pathog       Date:  2016-04-21       Impact factor: 6.823

Review 7.  Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.

Authors:  Paolo Manzoni; Josep Figueras-Aloy; Eric A F Simões; Paul A Checchia; Brigitte Fauroux; Louis Bont; Bosco Paes; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2017-06-26

8.  Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015-17.

Authors:  Hui Liu; David E Tabor; Andrey Tovchigrechko; Yanping Qi; Alexey Ruzin; Mark T Esser; Hong Jin
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

9.  Epidemiology and Molecular Characterization of Human Respiratory Syncytial Virus in Senegal after Four Consecutive Years of Surveillance, 2012-2015.

Authors:  Amary Fall; Ndongo Dia; El Hadj Abdel Kader Cisse; Davy E Kiori; Fatoumata Diene Sarr; Sara Sy; Debora Goudiaby; Vincent Richard; Mbayame Ndiaye Niang
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

10.  Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.

Authors:  Jeehyun Lee; Laura Klenow; Elizabeth M Coyle; Hana Golding; Surender Khurana
Journal:  PLoS Pathog       Date:  2018-08-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.